This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1097/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37474250
rdf:type
wikibase:Item
schema:description
article scientifique artigo científico bilimsel makale wetenschappelijk artikel научни чланак vedecký článok videnskabelig artikel scientific article published on July 2009 article científic مقالة علمية نشرت في يوليو 2009 wissenschaftlicher Artikel artículu científicu espublizáu en 2009 articolo scientifico vědecký článek vetenskaplig artikel наукова стаття, опублікована в липні 2009
p:P577
wds:Q37474250-634E4851-FB5C-4FFF-A617-10A556FDC6E5
wdt:P577
2009-07-01T00:00:00Z
p:P407
wds:Q37474250-E5EB86F9-F953-443C-B59A-F5F193C991DE
wdt:P407
wd:Q1860
rdfs:label
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia
skos:prefLabel
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia
schema:name
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia
p:P50
wds:Q37474250-06660DB9-2F51-4C93-95DF-071A255C07C8
wdt:P50
wd:Q65054871
p:P1476
wds:Q37474250-E14F2DC2-5E18-492C-A9EB-977D209E4648
wdt:P1476
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia
p:P304
wds:Q37474250-2A4B5583-6664-4201-8F06-ECFE6866BC8A
wdt:P304
372-379
p:P31
wds:Q37474250-1B2423F2-2F2F-4772-B7B7-5896107AF36E wds:Q37474250-93bac5b1-7a19-4271-b99e-62196b18de1e
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q37474250-0EC92FD2-9192-4C2E-A6E1-38EC6B3867EB wds:Q37474250-AEF66BEB-6378-45A9-823D-A4E0AAD679B5 wds:Q37474250-41E34635-B953-4381-9FA0-5F36C333CE5E
wdt:P921
wd:Q11068 wd:Q66291209 wd:Q12252367
p:P698
wds:Q37474250-BEE59B8B-0BF0-4BAA-A339-DB381B5312E5
wdtn:P698
n10:19424060
wdt:P698
19424060
p:P1433
wds:Q37474250-22CCCDB5-EEE0-45CB-9ED0-BE4849ADF9D4
wdt:P1433
wd:Q4626801
p:P433
wds:Q37474250-C01D1E26-9A59-4DA0-B898-4CEC046D9557
p:P478
wds:Q37474250-94F11B1B-CC00-42DE-81F7-1849619FE9E6
wdt:P433
4
wdt:P478
24
p:P356
wds:Q37474250-A88E9644-A0A6-4E34-BB39-0CD7EE77549E
wdtn:P356
n11:HCO.0B013E32832C0B3D
wdt:P356
10.1097/HCO.0B013E32832C0B3D